Previous close | 17.24 |
Open | 17.44 |
Bid | 0.00 x N/A |
Ask | 0.00 x N/A |
Day's range | 17.10 - 17.50 |
52-week range | 17.10 - 33.96 |
Volume | |
Avg. volume | 1,565 |
Market cap | N/A |
Beta (5Y monthly) | 0.39 |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
On May 2, 2024, Stephen Davis, the CEO of ACADIA Pharmaceuticals Inc (NASDAQ:ACAD), sold 11,427 shares of the company.
In order to justify the effort of selecting individual stocks, it's worth striving to beat the returns from a market...
ACADIA Pharmaceuticals Inc (NASDAQ:ACAD), a biopharmaceutical company focused on the development and commercialization of medicines to address unmet medical needs in central nervous system disorders, has reported an insider sell transaction.